You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MNPR Exercise Disclosure
Robinson Chandler · SEC Form 4 · Filed Oct 2, 2026
Exercise
Reported value range
Not reported
Robinson Chandler Chief Executive Officer
MNPR
Monopar Therapeutics
MNPR
Transaction date
Sep 30, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 2 days later
MNPR daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,801 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-031925
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$346.09K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monopar Therapeutics MNPR Current | Exercise | Sep 30, 2026 | Not reported |
| Monopar Therapeutics MNPR | Disposition | Sep 30, 2026 | $346.09K |
| Monopar Therapeutics MNPR | Exercise | Sep 30, 2026 | $0 |